Cencora, Inc. COR
306.92
(2.95)
(0.95%)
as of 25 Sep
- Market cap
- $59.1B
- P/E
- 22.7×
Follow COR
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cencora, Inc. (COR) P/S ratio
As of 25 September 2026, Cencora, Inc. (COR) trades at a P/S ratio of 0.2×. Over the past ten years it has ranged from 0.1× (March 2020) to 0.2× (November 2025); the current reading is higher than 87% of that period. That is below the Medical Distribution industry median of 0.2× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.2× | 24.01% |
| FY2024 | 0.2× | 9.91% |
| FY2023 | 0.1× | 17.01% |
| FY2022 | 0.1× | 2.87% |
| FY2021 | 0.1× | 9.95% |
| FY2020 | 0.1× | 8.52% |
| FY2019 | 0.1× | (20.02%) |
| FY2018 | 0.1× | 1.35% |
| FY2017 | 0.1× | 1.80% |
| FY2016 | 0.1× | (23.32%) |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 0.2× | (11.67%) |
| Mar 2026 | 0.2× | (7.70%) |
| Dec 2025 | 0.2× | 6.84% |
| Sep 2025 | 0.2× | 2.72% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.1×
High 0.2×
Ten-year median
0.1×
Current reading's percentile
87
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| YI 111, Inc. Sponsored ADR compare | 0.0× |
| ACH Accendra Health, Inc. compare | 0.0× |
| COR Cencora, Inc. | 0.2× |
| CAH Cardinal Health, Inc. compare | 0.2× |
| MCK McKesson Corporation compare | 0.3× |
| COSM Cosmos Health Inc. compare | 0.3× |
| HSIC Henry Schein, Inc. compare | 0.7× |
| AHG Akso Health Group Sponsored ADR compare | 0.9× |
| FOCL FocalTherics compare | 2.2× |
| Medical Distribution industry median | 0.2× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on COR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement